Literature DB >> 16702915

The role of the ossific nucleus in the treatment of established hip dislocation.

Andreas Roposch1, John H Wedge, Murray D Krahn.   

Abstract

UNLABELLED: Timing the reduction of a delayed presenting dislocated hip is controversial if the ossific nucleus of the proximal femoral epiphysis is absent. We formulated a decision model for management of 6- to 13-month-old infants based on two strategies: waiting for the ossific nucleus to appear before reducing the hip or immediate reduction. The model included the occurrence of long-term physical disability within a period of 20 years. A literature synthesis provided outcome probabilities. Outcome was measured by utilities derived by content experts. Waiting for the ossific nucleus was the preferred strategy with an expected value of 0.95 as opposed to 0.86 in the immediate reduction strategy. Sensitivity analyses showed the model was robust. Based on the results of decision analysis, reducing a dislocated hip in the presence of the ossific nucleus is likely to be the better strategy if avascular necrosis and long-term disability are considered. The difference between the two strategies is equivalent to one quality-adjusted life year, which is substantial. LEVEL OF EVIDENCE: Economic and Decision Analyses, Level II-1. See the Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2006        PMID: 16702915     DOI: 10.1097/01.blo.0000223975.13960.2d

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  2 in total

1.  Correlation between avascular necrosis and the presence of the ossific nucleus when treating developmental dysplasia of the hip.

Authors:  Sabit Sllamniku; Cen Bytyqi; Ardiana Murtezani; Emir Q Haxhija
Journal:  J Child Orthop       Date:  2013-10-22       Impact factor: 1.548

2.  Retrospective observational study comparing the international hip dysplasia institute classification with the Tonnis classification of developmental dysplasia of the hip.

Authors:  Mingyuan Miao; Haiqing Cai; Liwei Hu; Zhigang Wang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.